HIV-associated Hodgkin's disease

Int J STD AIDS. 2000 Aug;11(8):492-4. doi: 10.1258/0956462001916362.

Abstract

Hodgkin's disease (HD) appears to occur more frequently in people with HIV and within this population HD demonstrates a number of differences. In people with HIV, Epstein-Barr virus (EBV) is found more frequently in Reed-Sternberg cells and mixed cellularity and lymphocyte depleted histological subtypes predominate. Patients with HIV present with more advanced stage HD often with extranodal disease. The prognostic variables for HD in patients with HIV relate to the HIV rather than the HD. In people with HIV the response rates are lower, the relapse rates higher, the infectious complications more frequent and the overall survival worse than for HD in the general population.

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antiretroviral Therapy, Highly Active / methods
  • CD4 Lymphocyte Count
  • HIV Infections / blood
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • Herpesvirus 4, Human
  • Hodgkin Disease / diagnosis
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / epidemiology
  • Hodgkin Disease / immunology
  • Hodgkin Disease / virology*
  • Humans
  • Immunocompromised Host / immunology*
  • Incidence
  • Mechlorethamine
  • Prednisone
  • Procarbazine
  • Prognosis
  • Reed-Sternberg Cells / virology
  • Survival Analysis
  • Vincristine

Substances

  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Prednisone

Supplementary concepts

  • MOPP protocol